97 related articles for article (PubMed ID: 33061303)
1. Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based Virtual Screening and Investigation of Its Anti-Cancer Effect on Multiple Myeloma.
Yao R; Xie Y; Sun X; Zhang M; Zhou J; Liu L; Gao J; Xu K
Drug Des Devel Ther; 2020; 14():3983-3993. PubMed ID: 33061303
[TBL] [Abstract][Full Text] [Related]
2. Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo.
Dubiella C; Pinch BJ; Koikawa K; Zaidman D; Poon E; Manz TD; Nabet B; He S; Resnick E; Rogel A; Langer EM; Daniel CJ; Seo HS; Chen Y; Adelmant G; Sharifzadeh S; Ficarro SB; Jamin Y; Martins da Costa B; Zimmerman MW; Lian X; Kibe S; Kozono S; Doctor ZM; Browne CM; Yang A; Stoler-Barak L; Shah RB; Vangos NE; Geffken EA; Oren R; Koide E; Sidi S; Shulman Z; Wang C; Marto JA; Dhe-Paganon S; Look T; Zhou XZ; Lu KP; Sears RC; Chesler L; Gray NS; London N
Nat Chem Biol; 2021 Sep; 17(9):954-963. PubMed ID: 33972797
[TBL] [Abstract][Full Text] [Related]
3. Novel Midkine Inhibitor Induces Cell Cycle Arrest and Apoptosis in Multiple Myeloma.
Cheevapruk K; Ueno M; Sungwan P; Sittithumcharee G; Kariya R; Sampattavanich S; Okada S
Anticancer Res; 2024 Mar; 44(3):1023-1031. PubMed ID: 38423667
[TBL] [Abstract][Full Text] [Related]
4. Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production.
Ramos-Acosta C; Huerta-Pantoja L; Salazar-Hidalgo ME; Mayol E; Jiménez-Vega S; García-Peña P; Jordi-Cruz J; Baquero C; Porras A; Íñigo-Rodríguez B; Benavente CM; López-Pastor AR; Gómez-Delgado I; Urcelay E; Candel FJ; Anguita E
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732105
[TBL] [Abstract][Full Text] [Related]
5. Identification of antimycin A as a c-Myc degradation accelerator via high-throughput screening.
Liu Z; Ishikawa K; Sanada E; Semba K; Li J; Li X; Osada H; Watanabe N
J Biol Chem; 2023 Sep; 299(9):105083. PubMed ID: 37495110
[TBL] [Abstract][Full Text] [Related]
6. MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.
Ahmadi SE; Rahimi S; Zarandi B; Chegeni R; Safa M
J Hematol Oncol; 2021 Aug; 14(1):121. PubMed ID: 34372899
[TBL] [Abstract][Full Text] [Related]
7. In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia.
Boulos JC; Chatterjee M; Shan L; Efferth T
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627164
[TBL] [Abstract][Full Text] [Related]
8. Identification of WNK1 as a therapeutic target to suppress IgH/MYC expression in multiple myeloma.
Ye T; Mishra AK; Banday S; Li R; Hu K; Coleman MM; Shan Y; Chowdhury SR; Zhou L; Pak ML; Simone TM; Malonia SK; Zhu LJ; Kelliher MA; Green MR
Cell Rep; 2024 May; 43(5):114211. PubMed ID: 38722741
[TBL] [Abstract][Full Text] [Related]
9. Discovery of small molecule c-Maf inhibitors using molecular docking-based virtual screening, molecular dynamics simulation, and biological evaluation.
Hu Z; Zeng Y; Zhang Y; Zhang Q; Xu J; Liu L
Chem Biol Drug Des; 2024 Jan; 103(1):e14403. PubMed ID: 37984986
[TBL] [Abstract][Full Text] [Related]
10. Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells.
Li M; Zhang CL; Zhou DS; Chan SH; Liu XQ; Chen SN; Yang ZY; Ju FE; Sang XY; Liu ZX; Zhang QX; Pan YM; Deng SS; Wang XM; Zhong L; Zhang XD; Du X
Br J Haematol; 2024 Apr; 204(4):1307-1324. PubMed ID: 38462771
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of anti-PIK3CG treatment for multiple myeloma via inhibiting c-Myc pathway.
Di X; Pan Y; Yan J; Liu J; Wen D; Jiang H; Zhang S
Heliyon; 2024 Jan; 10(1):e23165. PubMed ID: 38163179
[TBL] [Abstract][Full Text] [Related]
12. Daptomycin Inhibits Multiple Myeloma Progression through Downregulating the Expression of RPS19.
Zhuang Y; Zhang Y; Chen C; Chen J; Xu Q; Wang P
Comb Chem High Throughput Screen; 2024 Mar; ():. PubMed ID: 38454765
[TBL] [Abstract][Full Text] [Related]
13. The MYC-Regulated RNA-Binding Proteins hnRNPC and LARP1 Are Drivers of Multiple Myeloma Cell Growth and Disease Progression and Negatively Predict Patient Survival.
Seibert M; Koschade SE; Stolp V; Häupl B; Wempe F; Serve H; Kurrle N; Schnütgen F; von Metzler I
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067212
[TBL] [Abstract][Full Text] [Related]
14. Timelapse viability assay to detect division and death of primary multiple myeloma cells in response to drug treatments with single cell resolution.
Mark C; Callander NS; Chng K; Miyamoto S; Warrick J
Integr Biol (Camb); 2022 Jun; 14(3):49-61. PubMed ID: 35653717
[TBL] [Abstract][Full Text] [Related]
15. Image-Based Analysis of Protein Stability.
Hickman KA; Hariharan S; De Melo J; Ylanko J; Lustig LC; Penn LZ; Andrews DW
Cytometry A; 2020 Apr; 97(4):363-377. PubMed ID: 31774248
[TBL] [Abstract][Full Text] [Related]
16. Editorial Expression of Concern: MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells.
Shi Y; Frost P; Hoang B; Yang Y; Fukunaga R; Gera J; Lichtenstein A
Oncogene; 2023 Oct; 42(41):3088. PubMed ID: 37626215
[No Abstract] [Full Text] [Related]
17. MYC inhibitor achieves phase I success.
Crunkhorn S
Nat Rev Drug Discov; 2024 Apr; 23(4):253. PubMed ID: 38448668
[No Abstract] [Full Text] [Related]
18. A Small Molecule Stabilizer of the MYC G4-Quadruplex Induces Endoplasmic Reticulum Stress, Senescence and Pyroptosis in Multiple Myeloma.
Gaikwad SM; Phyo Z; Arteaga AQ; Gorjifard S; Calabrese DR; Connors D; Huang J; Michalowski AM; Zhang S; Liu ZG; Schneekloth JS; Mock BA
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066043
[TBL] [Abstract][Full Text] [Related]
19. Real-world Data on the Efficacy and Safety of Ixazomib-based Therapy in Multiple Myeloma: A Single-center Study in China.
Ding K; Yu H; Shao YY; Li LY; Wang CM; Song J; Li LJ; Fu R
Cancer Manag Res; 2020; 12():8935-8941. PubMed ID: 33061589
[TBL] [Abstract][Full Text] [Related]
20. Turning Up the Heat on MYC: Progress in Small-Molecule Inhibitors.
Truica MI; Burns MC; Han H; Abdulkadir SA
Cancer Res; 2021 Jan; 81(2):248-253. PubMed ID: 33087323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
